Epigenetics Laboratory, Instituto Nacional de Medicina Genómica, Periferico Sur 4809, Arenal Tepepan, 14610, Mexico, CDMX, Mexico.
Laboratory of Connective Tissue, Instituto Nacional de Rehabilitación "Luis Guillermo Ibarra Ibarra". Calz., México-Xochimilco 289, Arenal de Guadalupe, 14389, Mexico, CDMX, Mexico.
Breast Cancer Res Treat. 2018 Sep;171(2):247-259. doi: 10.1007/s10549-018-4850-7. Epub 2018 Jun 9.
MicroRNAs constitute a large family of non-coding RNAs, which actively participate in tumorigenesis by regulating a set of mRNAs of distinct signaling pathways. An altered expression of these molecules has been found in different tumorigenic processes of breast cancer, the most common type of cancer in the female population worldwide.
The objective of this review is to discuss how miRNAs become master regulators in breast tumorigenesis.
An integrative review of miRNAs and breast cancer literature from the last 5 years was done on PubMed. We summarize recent works showing that the defects on the biogenesis of miRNAs are associated with different breast cancer characteristics. Then, we show several examples that demonstrate the link between cellular processes regulated by miRNAs and the hallmarks of breast cancer. Finally, we examine the complexity in the regulation of these molecules as they are modulated by other non-coding RNAs and the clinical applications of miRNAs as they could serve as good diagnostic and classification tools.
The information presented in this review is important to encourage new directed studies that consider microRNAs as a good tool to improve the diagnostic and treatment alternatives in breast cancer.
MicroRNAs 是一类非编码 RNA 大家族,它们通过调节一组不同信号通路的 mRNA 积极参与肿瘤的发生。这些分子的表达改变已在乳腺癌不同的肿瘤发生过程中被发现,乳腺癌是全球女性人群中最常见的癌症类型。
本综述的目的是讨论 miRNA 如何成为乳腺癌肿瘤发生的主要调控因子。
我们在 PubMed 上对过去 5 年中关于 miRNA 和乳腺癌的文献进行了综合回顾。我们总结了最近的研究工作,这些工作表明 miRNA 生物发生的缺陷与不同的乳腺癌特征相关。然后,我们展示了几个例子,这些例子表明 miRNA 调节的细胞过程与乳腺癌的标志之间存在联系。最后,我们研究了这些分子的调节复杂性,因为它们被其他非编码 RNA 所调节,并且 miRNA 具有作为良好的诊断和分类工具的临床应用。
本综述中提供的信息对于鼓励新的定向研究非常重要,这些研究将把 microRNAs 视为改善乳腺癌诊断和治疗选择的有效工具。